What is the role of NGS-based molecular profiling for providing roadmaps suggesting how combination, targeted therapy can produce improved clinical outcomes?

What is the role of NGS-based molecular profiling for providing roadmaps suggesting how combination, targeted therapy can produce improved clinical outcomes?

What is the role of NGS-based molecular profiling for providing roadmaps suggesting how combination, targeted therapy can produce improved clinical outcomes?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jean-Charles Soria, MD

Jean-Charles Soria, MD

Professor of Medicine and Medical Oncology South-Paris University Cancer Specialist Institut Gustave Roussy (IGR) Paris, France